Cargando…

Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical setting

PURPOSE: To describe the outcomes of a pharmacist-led multi-center, collaborative patient education and proactive adverse event management program in a community-based oncology setting. METHODS: Patients with EGFR mutation-positive (EGFRm+) non-small cell lung cancer, newly prescribed with oral afat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khrystolubova, Natasha, Shieh, Monica, Patel, Anjan J, Bailey, Ray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886115/ https://www.ncbi.nlm.nih.gov/pubmed/30832554 http://dx.doi.org/10.1177/1078155219833441

Ejemplares similares

Modeling Exposure‐Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib
por: Niebecker, Ronald, et al.
Publicado: (2019)

Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events
por: Logan, Jessica M., et al.
Publicado: (2021)

Cross-sectional Census Survey of Patients With Cancer who Received a Pharmacist Consultation in a Pharmacist Led Anti-cancer Clinic
por: Dennis, Madeleine, et al.
Publicado: (2022)

Analysis of a pharmacist-led adverse drug event management model for pharmacovigilance in an academic medical center hospital in China
por: He, Wei, et al.
Publicado: (2018)

Real‐World Clinical and Economic Outcomes in Selected Immune‐Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
por: Zheng, Ying, et al.
Publicado: (2021)

Correction to: Cross-sectional Census Survey of Patients With Cancer who Received a Pharmacist Consultation in a Pharmacist Led Anti-cancer Clinic
por: Dennis, Madeleine, et al.
Publicado: (2022)

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study
por: Ho, Gwo-Fuang, et al.
Publicado: (2019)

Improving Pharmacist-Led Pediatric Patient Education on Oral Chemotherapy at Home
por: Patel, Anika, et al.
Publicado: (2023)

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
por: Cottini, Francesca, et al.
Publicado: (2021)

Pharmacist-led minor ailment programs: a Canadian perspective
por: Taylor, Jeff Gordon, et al.
Publicado: (2016)

Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population
por: Goyal, Ravi K., et al.
Publicado: (2021)

Immune‐related adverse events and outcomes among pan‐cancer patients receiving immune checkpoint inhibitors: A monocentric real‐world observational study
por: Ge, Xiaoxiao, et al.
Publicado: (2023)

Afatinib as First-Line Treatment in Asian Patients with EGFR Mutation-Positive NSCLC: A Narrative Review of Real-World Evidence
por: Lu, Shun, et al.
Publicado: (2021)

The impact of community–pharmacist-led medication reconciliation process: Pharmacist-patient-centered medication reconciliation
por: AlAhmad, Mohammad M, et al.
Publicado: (2020)

The Impact of Pharmacist-Led Medication Management Services on the Quality of Life and Adverse Drug Reaction Occurrence
por: Brajković, Andrea, et al.
Publicado: (2022)

Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
por: Tamura, Kazuo, et al.
Publicado: (2019)

Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients
por: Chen, You-Yi, et al.
Publicado: (2021)

Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
por: Liang, Sheng-Kai, et al.
Publicado: (2017)

889. Early Discontinuations and Adverse Events Among Treatment-Naïve Patients Initiating Integrase Inhibitors in a Real-world Setting
por: Rolle, Charlotte-Paige M, et al.
Publicado: (2021)

Adverse events of different PD-1 inhibitors in lung cancer patients: a real-world study
por: Zheng, Xiaowei, et al.
Publicado: (2022)

Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study
por: Kobayakawa, Tomonori, et al.
Publicado: (2021)

Real-world evidence on impact of a pharmacist-led transitional care program on 30- and 90-day readmissions after acute care episodes
por: Bae-Shaaw, Yuna H, et al.
Publicado: (2020)

Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
por: Tamura, Kazuo, et al.
Publicado: (2019)

Adverse Events and Safety Profile of the COVID-19 Vaccines in Adolescents: Safety Monitoring for Adverse Events Using Real-World Data
por: Lee, Chae Won, et al.
Publicado: (2022)

Adverse events associated with molnupiravir: a real-world disproportionality analysis in food and drug administration adverse event reporting system
por: Liang, Yankun, et al.
Publicado: (2023)

Designing Adverse Event Forms for Real-World Reporting: Participatory Research in Uganda
por: Davies, Emma C., et al.
Publicado: (2012)

Adverse Events Associated With PCSK9 Inhibitors: A Real‐World Experience
por: Gürgöze, Muhammed T., et al.
Publicado: (2018)

Real-World Adherence to Toxicity Management Guidelines for Immune-Related Adverse Events
por: Teimouri, Arezou, et al.
Publicado: (2022)

Mandatory pharmacist-led education session for patients seeking medical cannabis
por: Parihar, Vikas, et al.
Publicado: (2020)

Utilizing Pharmacist-Led Telehealth Services in Ambulatory Patients with Heart Failure
por: Lugo Zamora, Ivanna L., et al.
Publicado: (2023)

Pharmacist-Led Implementation of Brief Tobacco Cessation Interventions during Mobile Health Access Events
por: Hudmon, Karen Suchanek, et al.
Publicado: (2023)

Comparative Adverse Kidney Outcomes in Women Receiving Raloxifene and Denosumab in a Real-World Setting
por: Chen, Hsin-Wei, et al.
Publicado: (2022)

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
por: Donaldson, Mark, et al.
Publicado: (2013)

Impact of a Pharmacist-Led Diabetes Management Intervention to Improve Health Equity
por: Smith-Ray, Renae, et al.
Publicado: (2021)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
por: Yin, Yanchao, et al.
Publicado: (2022)

A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
por: Yang, Yang, et al.
Publicado: (2022)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
por: Guo, Menglin, et al.
Publicado: (2022)

Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
por: Wencel, Mark L., et al.
Publicado: (2018)

Incidence of adverse cardiovascular events in patients with insomnia: A systematic review and meta-analysis of real-world data
por: Ali, Eman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_987smt10mpoq2fmapf1bfjjs2g